Brian Elsbernd

Companies

• Catalyst PharmaceuticalsGeneral counsel Jul 17, 2026 to now¹
• Catalyst PharmaceuticalsChief Compliance/Legal Officer Jan 4, 2019 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Catalyst Pharmaceuticals CPRX0 shares³Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 242,501 shares at $31.50 of Catalyst Pharmaceuticals³
• Dec 29, 2025Shares withheld for tax 2,623 shares of Catalyst Pharmaceuticals⁴
• Dec 29, 2025Exercised options 6,667 shares of Catalyst Pharmaceuticals⁴
• Dec 8, 2025Shares withheld for tax 2,780 shares of Catalyst Pharmaceuticals⁵
• Dec 8, 2025Exercised options 7,067 shares of Catalyst Pharmaceuticals⁵
• Nov 21, 2025Shares withheld for tax 2,030 shares of Catalyst Pharmaceuticals⁶
• Nov 21, 2025Exercised options 5,161 shares of Catalyst Pharmaceuticals⁶
• Nov 12, 2025Sold 40,000 shares at $22.70 of Catalyst Pharmaceuticals⁷
• Sep 8, 2025Sold 30,000 shares at $20.30 of Catalyst Pharmaceuticals⁸
• Sep 8, 2025Exercised options 112,475 shares at $2.24 of Catalyst Pharmaceuticals⁸
• Sep 4, 2025Sold 30,000 shares at $19.52 of Catalyst Pharmaceuticals⁹
• Sep 4, 2025Exercised options 30,000 shares at $2.24 of Catalyst Pharmaceuticals⁹
• Sep 3, 2025Sold 20,000 shares at $20.08 of Catalyst Pharmaceuticals⁹
• Sep 3, 2025Exercised options 20,000 shares at $2.24 of Catalyst Pharmaceuticals⁹
• Mar 3, 2025Sold 53,255 shares at $22.93 of Catalyst Pharmaceuticals¹⁰
• Mar 3, 2025Exercised options 53,255 shares at $2.24 of Catalyst Pharmaceuticals¹⁰
• Mar 3, 2025Sold 9,720 shares at $23.23 of Catalyst Pharmaceuticals¹⁰
• Mar 3, 2025Exercised options 9,270 shares at $2.24 of Catalyst Pharmaceuticals¹⁰
• Feb 14, 2025Shares withheld for tax 2,353 shares of Catalyst Pharmaceuticals¹¹
• Feb 14, 2025Exercised options 9,667 shares of Catalyst Pharmaceuticals¹¹
• Dec 27, 2024Shares withheld for tax 1,941 shares of Catalyst Pharmaceuticals¹²
• Dec 27, 2024Exercised options 6,667 shares of Catalyst Pharmaceuticals¹²
• Dec 9, 2024Shares withheld for tax 1,720 shares of Catalyst Pharmaceuticals¹³
• Dec 9, 2024Exercised options 7,067 shares of Catalyst Pharmaceuticals¹³
• Nov 26, 2024Sold 3,956 shares at $21.58 of Catalyst Pharmaceuticals¹⁴